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The importance of deep venous reflux velocity as a
determinant of outcome in patients with
combined superficial and deep venous reflux
treated with endovenous saphenous ablation
William A. Marston, MD, V. Wells Brabham, MD, Robert Mendes, MD, Daniel Berndt, BS,
Meredith Weiner, BS, and Blair Keagy, MD, Chapel Hill, NC
Introduction:Twenty to thirty percent of patients with symptomatic chronic venous insufficiency (CVI) are found to have
combined superficial and deep venous reflux on duplex testing. It is currently unclear whether endovenous ablation
(EVA) of the saphenous vein will result in correction of CVI without addressing the deep venous reflux. In this study, we
examined deep venous reflux velocities to determine whether these would predict outcome after endovenous ablation.
Methods: Patients with symptomatic CVI and both saphenous and deep venous reflux were identified using duplex
ultrasonography. Reflux times and maximal reflux velocity (MRV) in each examined vein segment were determined. In
each limb, the venous filling index (VFI) and the venous clinical severity score (VCSS) were obtained both before and after
laser ablation of the great and/or small saphenous veins. Preoperative venous reflux velocities were correlated with
improvement in VFI and VCSS after ablation.
Results: 75 limbs with both deep and superficial venous reflux were identified. Seventy-five percent of limbs were CEAP
clinical class 3 or 4 and the other 25% were class 5 or 6. Forty limbs demonstrated deep venous reflux in the femoral
and/or popliteal vein. After EVA, significant improvements in VFI and VCSS were seen, but this depended on MRV in
the deep vein. When MRV in the popliteal or femoral vein was<10 cm/sec, limbs had significantly better outcomes than
limbs with MRV >10 cm/sec as measured by both VFI (P  .01) and VCSS (P  .03). In 35 limbs, deep venous reflux
was identified only in the CFV. In this group, the average pre-procedure VFI (6.54  3.9 cc/sec) decreased significantly
to 2.2  1.9 cc/sec (P < .001) and the VCSS improved markedly from 7.0  2.8 to 1.3  1.4 (P < .001).
Conclusions: EVA of the saphenous veins can be performed in patients with concomitant deep venous insufficiency with
hemodynamic and clinical improvement in most cases. Patients with popliteal or femoral reflux velocities lower than 10
cm/sec usually experience marked improvement in both the VFI and the VCSS. Patients with femoral or popliteal reflux
velocities greater than 10 cm/sec have a high incidence of persistent symptoms after EVA. (J Vasc Surg 2008;48:400-6.)INTRODUCTION
Patients with symptomatic chronic venous insufficiency
(CVI) commonly are affected by abnormal venous reflux in
both the deep and superficial systems. In patients with class
5 and 6 CVI, 27.5% of patients were reported to have
combined disease1 and in another study, 22% of limbs with
primary superficial venous reflux also displayed reflux in the
deep system.2 Physicians commonly recommend removal
or ablation of the great and/or small saphenous veins to
treat symptomatic CVI for superficial reflux. Infrequently,
deep venous reconstruction is considered for patients with
deep venous reflux, usually in patients with severe symp-
toms recalcitrant to less invasive attempts at treatment. It is
currently difficult to predict whether patients who are
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400found to have both deep and superficial reflux will improve
if only the superficial reflux is addressed.
While some authors have reported deep venous reflux
resolution after saphenous vein stripping procedures,3,4
others have reported poor clinical outcomes after saphe-
nous removal in the presence of deep venous insufficiency.5
We have recently observed that patients with superficial
reflux commonly display low velocity reflux in the deep
veins, most often in the popliteal segment, that persists
longer than 0.5 seconds, satisfying the criteria for deep
venous reflux. The clinical significance of this low velocity
reflux is not well described.
Recently, endovenous methods of saphenous ablation
(EVA) have supplanted stripping procedures as the most
commonmethod of eliminating saphenous reflux.6,7 Using
radiofrequency or laser energy sources, EVA has been
found to reliably ablate the great or small saphenous vein
resulting in improved venous hemodynamics and control of
venous symptoms.8
The objective of this study is to determine whether
preoperative duplex criteria such as the deep venous reflux
velocity are predictive of hemodynamic and clinical out-
come after EVA of the saphenous vein(s) in patients with
combined deep and superficial venous insufficiency.
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Study design. Retrospective review of prospectively
collected case series.
Approval. This study was approved by the Biomedical
Institutional Review Board at the University of North
Carolina School of Medicine.
All patients with symptomatic CVI found to have both
deep and superficial reflux who were treated with en-
dovenous saphenous ablation were included in this study.
Abnormal venous reflux was determined using duplex ul-
trasound within a well documented protocol. Preopera-
tively, supine and standing reflux studies were performed to
map sites of venous reflux. Duplex ultrasonography was
performed with the patient in a supine position, using 30
degrees of reverse Trendelenburg. Commencing at the
saphenofemoral junction, the deep, superficial, and perfo-
rating veins were assessed with Doppler scan flow patterns
and B-mode imaging as previously described.9 Compres-
sion maneuvers and examination of flow patterns with
augmentation were utilized to identify the presence of
either acute or chronic venous obstruction and to deter-
mine the patency of the venous outflow tract.
Venous reflux in the deep and superficial venous sys-
tems was evaluated while the patient was in a standing
position, with their weight shifted to the contralateral limb.
A rapid inflation/deflation system (Hokanson E20 Rapid
Cuff Inflator and AG101 Cuff Inflator Air Source, Issa-
quah, Wash) and duplex ultrasound scan were used for this
examination. Systematic interrogation of the common fem-
oral, femoral, popliteal, great saphenous, and small saphe-
nous veins was conducted measuring valve closure times. A
cutoff valve closure time of 0.5 seconds was the criterion for
significant venous reflux for both the deep and superficial
venous systems. Perforating veins that were 3.5 mm in
size at the fascial level and demonstrated at least 0.5 sec-
onds of outward flow on compression and release of the calf
were defined as incompetent.10
The maximal reflux velocity (MRV) in the deep venous
system was determined for the common femoral, femoral,
and popliteal veins by examining the reflux velocity trac-
ings. The first 0.5 seconds of the reflux tracing were disre-
garded because the initial tracing reflected reflux prior to
valve closure and frequently included artifact in the signal.
Beginning at 0.5 seconds after cuff release until the end of
the reflux recording, the location of the highest velocity of
reflux was identified on the digital ultrasound record (see
Fig 1). Using the ultrasound’s digital cursor, the velocity
corresponding to this maximal reflux was determined. For
each waveform, the MRV can be measured in less than 15
seconds by an experienced vascular technologist.
Venous hemodynamicswere assessedusing an air plethys-
mograph (ACI Medical, Inc., Sun Valley, Calif). The venous
volume (VV) was measured initially, and reflux into the calf
was determined with calculation of the venous filling index
(VFI) as previously described by Christopolous et al.11
Three to six weeks after saphenous ablation, patients were
restudied with duplex to define the anatomic success ofablation and with APG to determine whether the VFI
corrected after the procedure. The anatomic outcome of
saphenous ablation was described as complete if the saphe-
nous vein was ablated with no flow from within 5 cm of the
saphenofemoral junction (SFJ) to the knee, partial if the
saphenous vein was ablated with no flow from 5-10 cm
distal to the saphenofemoral junction to the knee, and
unsuccessful if flowwas present in segments greater than 10
cm distal to the saphenofemoral junction.
Venous clinical severity scores (VCSS) were measured
at the patient’s initial clinic evaluation and after saphenous
ablation at the 3-6 week follow-up visit. Subsequent VCSS
were measured during clinic visits at 6-month intervals.
Scoring was tabulated as described previously with a maxi-
mum score of 30.12
EVA was performed utilizing an 810 nm laser source
and 600 um laser fiber as previously described.13 Mi-
cropuncture catheter/guidewire sets were used for GSV
access at or just below the knee. Sheath and laser fiber
introduction cephalad to the saphenofemoral junction was
performed under ultrasound guidance. The target to initi-
ate laser therapy was between 1 and 1.5 cm distal to the SFJ.
Peri-vein tumescence was performed utilizing saline con-
taining lidocaine and sodium bicarbonate over the entire
length of GSV to be treated. Laser energy was delivered at
14 watts and catheter pullback was continuous with the rate
targeted at one centimeter each 5-6 seconds to apply 70-80
joules of energy per cm of vein treated.
Ablation of varicose veins was performed immediately
after EVA if necessary using powered transilluminated phle-
bectomy as previously described. Limbs were compressed
with layered bandaging or compression hose and were
discharged fully ambulatory. Compression was maintained
for 2-4 weeks but was discontinued if the postoperative
studies revealed normal APG parameters.
Statistical analysis. Comparisons between pre- and
Fig 1. Measurement of maximal reflux velocity (MRV). In both
images, cuff release occurs at the first vertical line. The x-axis is time
with the large hash marks indicating 1 second. At 0.5 seconds after
cuff release, the velocity of reverse flow (in cm/sec) is identified
and recorded as MRV. A,High velocity reflux in the popliteal vein
of 38 cm/sec. B, Low velocity reflux in the popliteal vein of 8
cm/sec.post-EVA VFI and VCSS within groups were performed
JOURNAL OF VASCULAR SURGERY
August 2008402 Marston et alusing paired Student’s t-tests.14 Comparisons between the
VFI and VCSS after EVA in limbs with high MRV com-
pared with low MRV in the deep venous system were
performed using both parametric and non-parametric
methods. Modified t-tests (Satterthwaite) comparing the
means of VFI and VCSS in these two groups were con-
ducted and nonparametric tests were conducted to confirm
significance in which the outcome was dependant on nor-
malization of the VFI or reduction of the VCSS to less than
two. The association between the two dichotomous vari-
ables was tested using Chi-square analysis. Correlation
coefficients were obtained using standard Pearson regres-
sion analysis.
RESULTS
Between January 2004 andMarch 2007, 75 limbs in 70
patients with both deep and superficial reflux on duplex
ultrasound examination were treated with EVA. The distri-
bution of saphenous reflux involved the great saphenous
vein in 71 of 75 limbs and the small saphenous in 14 of 75
limbs. During this same time period, 261 limbs with super-
ficial reflux alone were treated with EVA. The average
patient age was 57 years and 70% were female. CEAP
classification is detailed in Table I. There are no clinical class
two patients because we have not recommended interven-
tion for patients with multisystem venous reflux who did
not have clinical class three or greater symptoms. The
anatomic distribution of abnormal deep venous reflux is
detailed in Table II. Using our definition, incompetent
perforators were identified in eight limbs (11%). No limbs
were treated with perforator ligation or ablation.
Outcome in all 75 limbs. The average preoperative
VFI in the entire group was 6.37  3.9 cc/sec. and the
average VCSS was 7.0. EVA was performed on the GSV
alone in 61 cases, the SSV alone in four cases, and both in
10 cases. Ablation of prominent varicosities with powered
Table I. CEAP criteria
Clinical class 3 4 5 6
Number limbs 49 7 14 5
Etiologic class Primary Secondary
Number limbs 62 13
Pathophysiology Reflux alone Obstruction alone Both
Number limbs 68 None 7
Table II. Distribution of reflux in segments of the deep
venous system
Segment Number of limbs
CFV alone 35
FV alone 0
PV alone 21
CFV and FV 6
CFV and PV 8
CFV, FV, and PV 5phlebectomy was performed in 58 cases (77%). EVA re-sulted in closure of the treated saphenous veins in 74 of 75
cases with one GSV found to have persistent flow in the
proximal 12 cm in the proximal thigh and occlusion of the
more distal segment of the vein.
Post-ablation follow-up for at least six months was
obtained in 57 limbs (76%). Median follow-up time was
13.1 months. All patients completed their initial follow-up
at 3-6 weeks with measurement of post-procedure VFI and
VCSS for inclusion in endpoint analysis. In the entire
group, EVA resulted in a significant improvement in ve-
nous hemodynamics with the post-procedure VFI falling to
2.67 2.3 cc/sec (P .01). A significant improvement in
VCSS was also noted with the median VCSS at the last
follow-up visit of 1.9  2.2 (P  .001).
Limbs with deep reflux in the femoral and/or pop-
liteal veins. In 40 limbs, deep venous reflux was noted in
the femoral and/or popliteal veins. The VFI before EVA in
this group of patients was markedly abnormal (6.2  3.8)
and improved significantly after EVA to 3.3  3.0 (P 
.001). The VCSS before EVA (7.7  2.5) also improved
significantly after EVA to 2.6  2.7 (P  .001). This
improvement was dependant on the MRV in the most
distal deep venous segment displaying abnormal reflux.
The most distal segment was the femoral in six limbs and
the popliteal in 34 limbs. If the MRV in this most distal
refluxing deep vein was 10 cm/sec, the improvement in
VFI and VCSS were significantly less than in limbs where
the MRV in the distal deep venous segment was 10
Table III. Pre- and postoperative VFI measured by air
plethysmography in patients treated with EVA of the
superficial system with high versus low preoperative deep
venous reflux velocity in the femoral or popliteal vein
VFI before
EVA
VFI after
EVA
P value before
vs after EVA
Low MRV 5.4  2.3 2.2  2.3 .001
High MRV 6.9  4.7 4.4  3.2 .007
P value low vs
high MDRV NS .01
VFI, Venous filling index; MRV, maximal reflux velocity in the femoral or
popliteal vein; EVA, endovenous ablation.
Table IV. Pre- and postoperative VCSS in patients
treated with EVA of the superficial system with high
versus low preoperative deep venous reflux velocity in the
femoral or popliteal vein
VCSS before
EVA
VCSS after
EVA
P value before
vs after EVA
Low MRV 7.1  2.1 1.6  0.9 .001
High MRV 8.2  2.7 3.5  3.5 .001
P value low vs
high MDRV NS .03
VCSS, Venous clinical severity score; MRV, maximal deep reflux velocity in
the femoral or popliteal vein; EVA, endovenous ablation.cm/sec (Tables III and IV). Limbs were significantly more
eflux
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range when the preoperative MRV was10 cm/sec (15 of
19 limbs) than when the preoperative MRV was 10
cm/sec (five of 21 limbs, P  .01 by Chi square test). The
correlation coefficient between preoperative deep vein
MRV and the postoperative VFI was 0.55. There were
three outliers with high MRV who experienced correction
of the VFI and VCSS after EVA. These limbs were found to
have had high velocity reflux in the popliteal vein and SSV
that was treated with EVA of the SSV, which likely resulted
in correction of the popliteal reflux. After removing limbs
treated with EVA of the SSV from analysis, the correlation
coefficient between deep vein MRV and post-procedure VFI
was 0.87 (P  .01, Fig 2). In the group of limbs with high
deep venous MRV who did not undergo EVLA of the SSV,
only one of 15 limbs experienced normalization of the VFI
after EVLA of the superficial system. Of note, even in the
groupwith highMRV in the deep venous system, significant
improvement in the VCSS was noted after EVLA, but the
post procedure VCSS was significantly higher than in limbs
with a low deep venous MRV (Table IV).
Limbs with deep reflux limited to the common
femoral vein. Thirty-five limbs were identified with super-
ficial reflux and deep venous reflux confined to the com-
mon femoral vein. In this group, the VFI decreased signif-
icantly after EVA (P  .001) and the VCSS improved
significantly after EVA (P  .001) as represented in Fig 3.
The MRV in the CFV was not related to outcome because
29 of 35 limbs experienced resolution of their venous
hemodynamics with a normal VFI and only four patients in
this group reported a VCSS greater than two at follow-up
visits.
DISCUSSION
Patients presenting with chronic venous insufficiency
are frequently found to display reflux in both the deep and
superficial venous systems. In the current series of patients
Fig 2. Correlation between pre-ablationMaximal Reflu
in limbs with GSV reflux and femoral and/or popliteal rundergoing endovenous ablative procedures, this anatomywas identified in 22% of limbs. EVA is a relatively low risk
procedure that may be performed in an office setting under
local anesthesia with a typically short recovery time.6,7
Procedures that are currently utilized to correct deep ve-
nous insufficiency such as valve repair or valve transfer
techniques are more invasive procedures requiring a longer
recovery time yielding variable results.15 Most physicians
treating patients with combined superficial and deep venous
insufficiency would consider initial ablation of the superficial
systemwithout addressing the deep venous reflux. In patients
with persistent symptoms after superficial ablation, deep ve-
nous reconstruction can then be considered.
The identification of criteria predictive of symptomatic
improvement after saphenous ablation alone would aid
significantly in the management of this group of patients.
Those with criteria predictive of improvement may proceed
to EVA while those with criteria predictive of persistent
symptoms after EVA may wish to consider other treatment
options, or if they proceed with EVA, it is with the knowl-
city (MRV) and post-ablation venous filling index (VFI)
(limbs with SSV reflux removed).
Fig 3. Venous filling index (VFI) and Venous Clinical Severity
Score (VCSS) before and after endovenous ablation (EVA) in
patients with saphenous reflux and deep venous reflux in the
common femoral vein (P  .001 for both VFI and VCSS).x Veloedge that symptoms may persist despite the procedure.
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of 11 limbs with deep and superficial disease treated with super-
ficial stripping and perforator ligation in some cases.16 Although
only 27% of limbs studied postoperatively were found to have
correction of deep venous reflux, marked hemodynamic
improvement was demonstrated. The venous filling index
decreased from 12 ml/sec preoperatively to 2.7 ml/sec
postoperatively, and clinical symptom scores decreased
from 10 to 1.4. Themajority of limbs in this study displayed
primarily proximal reflux. These and other authors have
reported that patients with superficial and deep reflux iso-
lated to the common femoral vein will experience correc-
tion of the deep venous reflux after superficial venous
ablation. This occurs due to the lack of valves in the
common femoral vein in most limbs. Therefore reflux in
the GSV results in reflux in the more proximal common
femoral from tributaries up to a competent iliac vein valve.
When considering deep venous reflux involving the
femoral and popliteal veins, there is contradictory informa-
tion concerning the ability of superficial ablation to correct
deep venous reflux. Walsh et al and Sales et al reported
resolution of deep venous reflux after GSV stripping in over
90% of cases,3,4 but Scriven et al reported that deep venous
reflux usually did not correct after superficial stripping.5
Adam et al reported that deep venous reflux confined to
either the femoral or popliteal segments corrected in 50% of
limbs after superficial venous surgery, and limbs with ulcers
healed in 77% of cases.17 Puggioni et al recently reported a
study of 38 limbs with combined deep and superficial reflux
studied with duplex ultrasound before and after saphenous
stripping.18 Deep venous reflux was corrected in one third
of patients, and femoral vein reflux corrected more frequently
when only segmental reflux was present in that vein rather
than axial reflux throughout the deep venous system. The
authors concluded that superficial ablative procedures rarely
improve deep venous reflux in limbs with axial reflux and that
further long-term study is required to determine the effects of
superficial procedures on the deep venous system.
In their methodology, Puggioni et al describe a classi-
fication system for peak reflux velocity in the deep venous
system, but did not report that this correlated to outcome
after superficial venous ablation.18 We have elected to
define MRV at 0.5 seconds after release of compression
because many vein segments will display a brief initial high
velocity burst of reflux prior to valve closure. We believe
that measuring theMRV at the time that persistent reflux is
defined as abnormal eliminates spuriously elevated values
generated by the diagnostic test itself. It is possible that
other methods of defining venous reflux in the deep venous
segmentsmay yield better predictive results such as an average
velocity of reflux over time as proposed by Delis et al for the
evaluation of perforator reflux.19 This and other potential
predictors will be evaluated in ongoing studies.
There exists some disagreement concerning the defini-
tion of abnormal deep venous reflux with some authors
using 0.5 seconds as the cutoff for abnormal reflux and
others using 1 second as the cutoff. We have used 0.5
seconds as our definition and in this series only three limbswere included with a reflux value between 0.5 and 1 second
in the deep venous segment. Reviewing the results without
these three limbs included, we found no significant changes
in the findings of the statistical review.
In this study we elected to measure outcomes using the
VFI and VCSS. The VFI as measured by air plethysmogra-
phy has been validated as a reproducible measure of the
severity of CVI.11 The VFI has also been found to predict
the long-term symptomatic outcome for patients after ve-
nous surgical procedures. Owens et al reported that 94% of
patients in whom the VFI corrected to 2 ml/sec imme-
diately after venous surgery were asymptomatic at a mean
follow-up time of 44 months.20 The VCSS was developed
as a clinically relevant measure of disease severity and has
been found to be useful in reflecting changes in the severity
of venous insufficiency after venous procedures.21,22 In
Meissner et al’s report validating the VCSS, it was found to
correlate well with CEAP clinical class allowing definition of
absent venous disease (VCSS score 3), mild to moderate
disease (4 to 7), and severe (8) disease categories.23 We
elected to use these measures rather than repeating duplex
scanning of the deep venous segments to provide information
on clinically relevant outcomes. Although it would have been
interesting to seewhether deep venous refluxwas abolished or
persistent from a scientific standpoint, this means little if
clinically relevant measures do not improve.
The results of this analysis agree with those of previous
authors who have noted correction of common femoral
vein reflux after great saphenous removal. Similarly, with
EVA, our patients experienced correction of the VFI in
most cases with a corresponding decrease in VCSS to an
average of 1.3 after EVA. In the absence of FV or PV reflux
it appears that CFV reflux is benign and should not affect
the potential for benefit from superficial venous ablation.
Patients with deep venous reflux in the femoral and/or
popliteal veins were less likely to completely correct their
venous hemodynamics as measured by VFI after superficial
venous ablation. However, there was improvement in this
parameter as well as the VCSS in most patients. We found
that the MVR in the most distal refluxing deep vein,
popliteal or femoral, was predictive of outcome after EVA
as measured by VFI and VCSS. The association was partic-
ularly strong when patients with prominent reflux in the
SSV were removed from analysis. Prominent SSV reflux is
likely to increase the duration and velocity of reflux in the
popliteal vein, even if the valve proximal to the saphenopop-
liteal junction is competent. It is important to measure reflux
in the popliteal vein distal to the saphenopopliteal junction to
minimize this variable, but this is not always possible given the
anatomic variability of the junction.Wewere not able to verify
the location ofmeasurement of popliteal vein reflux in all cases
so it is possible that some were measured above the junction
yielding spuriously high velocities.
Limbs with a highMRV and no SSV reflux pre-ablation
were rarely found to normalize the VFI and VCSS post-
ablation, although some experienced amodest improvement
in these parameters. Patients with a low pre-procedure MRV
experienced significantly better outcomes with a lower VFI
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ful to evaluate options for patients with combined deep and
superficial disease. Those with a low MRV can be counseled
that EVA is likely to result in improvement or correction of
their symptoms, while those with an unfavorable MRV can
be counseled prior to intervention that they may have
persistent symptoms after ablation allowing them to con-
sider other therapeutic options.
Further study of deep venous tracings in a larger group
of patients is required to confirm the information presented
here. It must be acknowledged that the number of patients
with popliteal or femoral reflux and great saphenous reflux
is relatively limited (n  28) and analysis with a larger
sample size may yield stronger associations. Longer clinical
follow-up would also be useful to determine the durability
of the results after EVA in this patient population. We also
have not yet evaluated the effect of venous outflow obstruc-
tion or incompetent perforators on reflux velocities in the
femoral and popliteal veins. It is possible that correction of
outflow obstruction or perforator incompetence in patients
with distal deep reflux may result in decreased MRV as a
source of symptomatic improvement.
CONCLUSIONS
EVA of the saphenous veins can be performed in pa-
tients with concomitant deep venous insufficiency with
hemodynamic and clinical improvement in most cases.
Patients with femoral or popliteal MRV lower than 10
cm/sec usually experience marked improvement in VFI
and VCSS. Patients with femoral or popliteal reflux veloc-
ities greater than 10 cm/sec in the absence of SSV reflux
have a high incidence of persistent symptoms after EVA.
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Dr. Cynthia Shortell (Durham, NC). I would like to start by
commending Dr. Marston and his colleagues on an extraordinarilyhighly relevant topic to those of interested in venous disease.
Specifically, the authors address the relevance of deep reflux in the
setting of the treatment of superficial reflux. In the 1990s, Dr. John
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August 2008406 Marston et alBergan was one of the first people to identify the fact that some
deep reflux can be corrected by treating superficial reflux. While a
large percent is corrected, there are a significant number of patients
with deep reflux in whom superficial ablation does not correct their
deep reflux. In this paper, Dr. Marston and his colleagues finished
that thought very nicely by identifying the means by which patients
who will improve and those that will not can be differentiated. I do
have a few questions for the authors. First of all, duplex evaluation
does not provide optimal evaluation of iliac vein involvement; and
specifically one is concerned about iliac vein obstruction, and you
did mention a significant number of your patients had a secondary
etiology. Albeit infrequently, this can play a significant role in
looking at infrainguinal reflux and its presence changes the man-
agement of this problem markedly. How do you decide in your
practice whether or not to look for iliac vein lesions such as stenosis
and occlusion and how often is this necessary in your opinion?
Next, in the manuscript I was surprised to see that you didn’t
specifically discuss perforator status on your patients. Do you
routinely look for them, and what role do you think perforators
play in the improvement of symptoms and the change in VFI after
ablation? Specifically, do you think that the treatment of perfora-
tors ever changes a high MRV to a low MRV? I was wondering if
that might be a way to change the prognosis for some of those high
MRV patients. I was interested in the fact that you treat all patients
with varicose veins at the time of your EVA; we actually do a staged
treatment. I was wondering if that reflected the fact that you were
in the camp that believes all patients with varicose veins should
have them removed if they are large because they serve as a later
reservoir for reflux and they contribute to recurrence, or whether
this was more of a convenience of practice protocol. I also wanted
to know how hard the measurement of MRV was for a non-
academic lab as most venous labs are. Is it something that could
readily be applied in general practice so that the non-academic
practitioners could use this as a way of differentiating the appro-
priate from the nonappropriate patients, although one wonders if
that is something that one wants to do. Then, what is your
follow-up protocol? You addressed this a little bit in one of your
slides. Do you use the VCSS and the VFI as sort of a screening tool
to do follow-up duplex? We know that a significant number of
patients will progress or recur after treatment and I was wonderingif you do any routine follow-up duplex of the entire venous system
or only as clinical symptoms warranted. Lastly, I was interested in
knowing what your personal practice is now. Do you offer ETA
with patients with the high MRV? What is your percentage of
indication for deep venous intervention, what sort of intervention
do you use? Have you had any experience with percutaneous
valves?
Dr. William Marston. Thank you Dr. Shortell for those
insightful comments. We do look for iliac vein obstruction and
perforator involvement in all limbs with venous insufficiency. Since
Drs Raju and Neglen have educated us on the frequency of iliac
involvement, we have become more aggressive in looking for and
treating iliac outflow obstruction. Our thoughts on incompetent
perforators have been well documented in the past in a study in
which we found that the majority of incompetent perforators are
no longer incompetent after superficial surgery and varicosity
ablation alone. So our preference is to treat the superficial disease
first, and if the perforators remain, we will treat them later.We have
not yet studied the effect of iliac vein stenting or perforator
ablation on MRV, but I think that is an excellent question. I
personally like to take the varicosities for the more severe patients,
the classes 4-6, and get all those out of there up front. For less
severely affected patients, you can manage the varicosities however
you want based on your practice situation and your patients’
preferences. The MRV is not a difficult measurement to make and
if you just look at the reflux waveforms instead of just looking at a
report, it is easy to tell the difference between a low and highMRV.
It is an easy measurement for the vascular technologists to do and
it doesn’t take much time, less than 20 seconds per tracing.
Basically, my practice now is to always consider ablating the
superficial system in patients with combined deep and superficial
disease as it is possible to get some improvement even in the severe
cases. But I think it is really important to tell the patients ahead of
time that if they have a highMRV it is possible that their symptoms
may not improve entirely. You might need to perform further
intervention to correct their symptoms. In higher risk patients with
combined disease and a high MRV, it may be better to avoid
superficial intervention as there is a lower chance of symptomatic
improvement.
